Characteristic | Baseline value | SD | Reference |
---|---|---|---|
Demographics | Â | Â | Â |
Mean age (years) | 56.1 | 9.8 | 25 |
Duration of diabetes (years) | 7.9 | 5.4 | 25 |
Proportion male (%) | 49.4 | Â | 25 |
Risk factors | Â | Â | Â |
HbA1c (%) | 8.4 | 0.9 | 25 |
SBP (mmHg) | 132.1 | 15.4 | 25 |
BMI (kg/m2) | 29.9 | 5.1 | 25 |
Total cholesterol (mg/dl) | 196.15 | 42.3 | 25 |
LDL (mg/dl) | 130.76 | 38.46 | 25 |
HDL (mg/dl) | 50 | 11.53 | 25 |
Triglycerides (mg/dl) | 190.9 | 145.5 | 25 |
Ethnic group (%) | Â | Â | Â |
   White | 64.5 |  | Novo Nordisk, data on file |
   Black | 2.9 |  | Novo Nordisk, data on file |
   Asian | 32.5 |  | Novo Nordisk, data on file |
Cardiovascular disease | Â | Â | Â |
Stroke (%) | 0.9 | Â | Novo Nordisk, data on file |
Angina pectoris (%) | 1.0 | Â | Novo Nordisk, data on file |
MI (%) | 1.4 | Â | Novo Nordisk, data on file |
CHF (%) | 0.1 | Â | Novo Nordisk, data on file |
Atrial fibrillation (%) | 1.5 | Â | Novo Nordisk, data on file |
LVH by ECG (%) | 0.7 | Â | Novo Nordisk, data on file |
PVD (%) | 0.8 | Â | Novo Nordisk, data on file |
Renal disease | Â | Â | Â |
Microalbuminuria (%) | 1.1 | Â | Novo Nordisk, data on file |
Gross proteinuria (%) | 0.1 | Â | Novo Nordisk, data on file |
End-stage renal disease (%) | 0.1 | Â | Novo Nordisk, data on file |
Retinopathy | Â | Â | Â |
Background diabetic retinopathy (%) | 14.9 | Â | Novo Nordisk, data on file |
Proliferative diabetic retinopathy (%) | 0.1 | Â | Novo Nordisk, data on file |
Other complications | Â | Â | Â |
Peripheral neuropathy (%) | 20.0 | Â | Novo Nordisk, data on file |
Foot ulcer (%) | 0.1 | Â | Novo Nordisk, data on file |
Amputation (%) | 0.3 | Â | Novo Nordisk, data on file |
Cataract (%) | 5.6 | Â | Novo Nordisk, data on file |
Macular edema (%) | 0.2 | Â | Novo Nordisk, data on file |
Severe vision loss (%) | 0.1 | Â | Novo Nordisk, data on file |
Patient management | Â | Â | Â |
ACE-I/ARBs (%) | 48.7 | Â | 18 |
Statins (%) | 28.2 | Â | 18 |
Aspirin (%) | 43.9 | Â | 18 |
Screened for retinopathy (%) | 67.7 | Â | 39 |
Screened for renal disease (%) | 55 | Â | 40 |
Screened for foot disease (%) | 68.3 | Â | 39 |